Trial Profile

A phase IIb study of LIB-01 for the treatment of erectile dysfunction

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 31 Dec 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Dec 2025 According to Dicot Pharma media release,the company has signed an agreement with a global contract research organization (CRO) to prepare for this study.As part of the preparations, the study design will be finalized, the study protocol developed, and relevant documentation compiled for submission of applications to initiate clinical studies in each region: Investigational New Drug (IND) in the US, and a Clinical Trial Application (CTA) in Europe.
20 Nov 2025 New trial record
23 Oct 2025 According to Dicot Pharma media release, the company plans to initiate the trial in 2026.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com